XML 198 R48.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes (Tables)
12 Months Ended
Sep. 30, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax (Expense) Benefit
The components of income tax (expense) benefit for the years ended September 30, 2024, 2023 and 2022 are as follows:
 Year Ended September 30,
202420232022
Current (expense) benefit:
United States federal$(6,256)$(97)$(17)
State(2,629)(1,032)(1,065)
Total current (expense) benefit (8,885)(1,129)(1,082)
Deferred (expense) benefit:
United States federal(4,682)(4,190)2,380 
State(662)(446)4,109 
Total deferred (expense) benefit (5,344)(4,636)6,489 
Total income tax (expense) benefit $(14,229)$(5,765)$5,407 
Schedule of Reconciliation of Tax Rate
The income tax provision differs from the tax that would result from application of the statutory federal tax rate of 21% to pre-tax income for the years ended September 30, 2024, 2023 and 2022. The reasons for the differences are as follows:
 Year Ended September 30,
202420232022
Income tax expense at statutory rate$(11,808)$(3,798)$(4,293)
State income taxes, net of federal tax benefit(2,611)(1,188)(1,356)
Excess officers compensation(659)(387)(276)
Transaction Costs— (479)— 
Adjustment to deferred taxes(801)(322)(345)
R&D Credits Generated500 546 — 
Decrease in valuation allowance808 236 12,075 
Other, net342 (373)(398)
Total income tax (expense) benefit$(14,229)$(5,765)$5,407 
Schedule of Components of Deferred Tax Assets (Liabilities)
The components of the deferred tax assets (liabilities) recorded in the accompanying consolidated balance sheets were as follows:
September 30,
20242023
Gross deferred tax assets:
Operating lease liability$42,749 $47,349 
Deferred compensation596 558 
Accrued compensation2,497 2,636 
Accrued tool sets1,255 1,069 
Other reserves and accruals5,750 4,464 
Deferred revenue3,501 4,733 
Net operating losses5,044 9,232 
Tax credit carryforwards632 929 
Capitalized R&D costs3,085 3,109 
September 30,
20242023
Charitable contribution carryovers628 1,223 
Deductions limited by Section 382— 
Other86 84 
Valuation allowance(2,012)(3,192)
Total gross deferred tax assets63,811 72,199 
Gross deferred tax liabilities:
Right of use assets for operating leases(40,189)(44,726)
Amortization of goodwill and intangibles(5,513)(5,540)
Depreciation and amortization of property and equipment(17,401)(16,829)
Prepaid and other expenses deductible for tax(1,535)(1,241)
  Other comprehensive income(306)(758)
Total gross deferred tax liabilities(64,944)(69,094)
Net deferred tax (liabilities) assets$(1,133)$3,105 
Schedule of Valuation Allowance
The following table summarizes the activity for the valuation allowance for the years ended September 30, 2024, 2023 and 2022:
Year Ended September 30,
202420232022
Balance at beginning of period$3,192 $1,200 $13,492 
Reductions to income tax— (236)(12,075)
Write-offs/Adjustments(1)
(1,180)2,228 (217)
Balance at end of period$2,012 $3,192 $1,200 
(1) The fiscal year 2024 balance primarily relates to finalizing the purchase accounting for the Concorde acquisition.
Schedule of Unrecognized Tax Benefits
The following table summarizes the activity related to the gross unrecognized tax benefits for the fiscal years ended September 30, 2024 and 2023:
Year Ended September 30,
20242023
Balance at beginning of period$496 $387 
Increases relates to current year tax positions100 109 
Balance at end of period$596 $496